StonvexLoading…
StonvexStonvexStonvexCore line items from BLMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $1.02B | $1.06B | $3.96B | $2.98B | $2.05B |
Operating Income | Not available | $59.10M | $37.16M | $50.46M | $86.88M |
Net Income | Not available | $55.65M | $8.24M | $21.71M | $67.57M |
EPS (Diluted) | $0.29 | $0.65 | $0.10 | $0.25 | $0.79 |
Total Assets | Not available | $3.11B | $3.17B | $3.28B | $3.31B |
Total Liabilities | Not available | $2.72B | $2.83B | $2.93B | $2.91B |
Cash & Equivalents | Not available | $71.30M | $59.46M | $66.48M | $50.31M |
Free Cash Flow OCF − CapEx | Not available | $50.12M | $96.77M | $33.10M | $38.83M |
Shares Outstanding | Not available | 85.41M | 85.22M | 85.17M | 85.06M |